# Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

> **NCT06234748** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 19 (actual)

## Conditions studied

- Oropharynx Cancer
- HPV-Related Carcinoma

## Interventions

- **RADIATION:** Radiation
- **DRUG:** Platinum based chemotherapy

## Key facts

- **NCT ID:** NCT06234748
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-20
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234748, "Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06234748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*